The flagship site for Pillar has Phase 1-4 capabilities with a dedicated outpatient and a 50-bed inpatient research unit.
Located between the northern suburbs of Chicago and the heart of downtown, Pillar's Chicago facility has outpatient space, a 24-bed inpatient research unit, and a dedicated Phase I unit with an additional 20 beds. The Chicago facility conducts Phase 1-4 studies.
Located in Arkansas' capital, Pillar's Little Rock facility has dedicated outpatient space as well as access to an 8-bed inpatient unit. The Little Rock location conducts Phase 1-4 studies.
The modern facility includes a 24-bed inpatient unit, a 24-bed Phase 1 unit, and an indoor smoking lounge. The NWA location has experienced clinical research staff, capable of conducting both inpatient and outpatient Phase 1-4 clinical trials.
DALLAS
CHICAGO
NORTHWEST ARKANSAS
CENTRAL ARKANSAS
Business Hours
Monday – Friday
8:30 a.m. – 5 p.m.
Since the beginning of the COVID-19 pandemic, the Pillar team has been continuing to put patient safety at the forefront. We have been following all CDC and state guidelines regarding operations and safe social distancing procedures. We will continue to conduct as much business as possible via phone calls and telehealth, where appropriate. All visitors to our sites are screened and temperature checked before entry. Proper PPE is also utilized by staff and provided for patients. We are continuing with several new studies and appreciate your continued support throughout these challenging times!
Sign up to receive updates, promotions, and sneak peaks of Swab Test.
